Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: People with diabetes are at high risk for cardiovascular events regardless of known heart disease. Physicians may underrecognize the excess cardiovascular risk conferred by diabetes alone, without a recent cardiovascular event. Other disparities in the receipt of lipid-lowering medications (LLMs) may exist. METHODS: We studied veterans with diabetes in fiscal years 1998 and 1999 cross-sectionally. We used administrative data (demographic information, International Classification of Diseases, Ninth Revision [ICD-9] codes, utilization information, medications, and laboratory tests) to evaluate associations between use of LLMs and age, ethnicity, sex, marital status, Charlson Index, heart disease ICD-9 codes, oral agents and insulin, hospitalization status, and low-density lipoprotein cholesterol levels. We constructed separate logistic regression models to evaluate associations between low-density lipoprotein cholesterol and similar predictor variables. RESULTS: Odds ratios were similar in both years. For fiscal year 1999, patients without recent ICD-9 codes in their administrative data indicating heart disease were 0.35 times less likely to be given LLMs than those with such codes. Individuals older than 75 years were 0.65 times less likely to be given LLMs than those younger than 65 years. African Americans were 0.72 times less likely than whites to be given LLMs. In fiscal years 1999 and 1998, 27% and 36% of individuals given LLMs had low-density lipoprotein cholesterol levels higher than 130 mg/dL (3.37 mmol/L). CONCLUSIONS: Veterans with diabetes but no recently coded heart disease, older individuals, and African Americans could benefit from programs targeted to introduce LLMs. Up to one third of individuals given LLMs remained above the target level of 130 mg/dL for low-density lipoprotein cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Primary Care Outcomes in Patients Treated by Nurse Practitioners or Physicians: A Randomized Trial
Mundinger, M. O., Kane, R. L., Lenz, E. R., Totten, A. M., Tsai, W.-Y., Cleary, P. D., Friedewald, W. T., Siu, A. L., & Shelanski, M. L. (2000) · JAMA · doi:10.1001/jama.283.1.59 · Cited by 955 · cited 2×
“Despite these data and effective, welltolerated lipid-lowering medications (LLMs), many studies reveal that individuals with diabetes are often found to have LDL-C levels above the recommended targets.(23-33) This gap between evidence and practice has motivated many health care systems to benchmark their diabetes care…”
BackgroundMethodManagement of Dyslipidemia in Adults With Diabetes
Haffner, S. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.160 · Cited by 786
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712
Miettinen, T. A., Pyörälä, K., Olsson, A. G., Musliner, T. A., Cook, T. J., Faergeman, O., Berg, K., Pedersen, T., Kjekshus, J., & Group, F. T. S. S. S. (1997) · Circulation · doi:10.1161/01.cir.96.12.4211 · Cited by 508 · cited 1×
“5 years of treatment with a statin.(48) Older individuals were less likely to be treated with LLMs than younger individuals in both years, even after adjusting for the lower mean level of LDL-C in the older group.”
BackgroundKiefe, C. I., Allison, J. J., Williams, O. D., Person, S. D., Weaver, M. T., & Weissman, N. W. (2001) · JAMA · doi:10.1001/jama.285.22.2871 · Cited by 503
Identifying Persons with Diabetes Using Medicare Claims Data
Hebert, P. L., Geiss, L. S., Tierney, E. F., Engelgau, M. M., Yawn, B. P., & McBean, A. M. (1999) · American Journal of Medical Quality · doi:10.1177/106286069901400607 · Cited by 403 · cited 1×
“We utilized the HEDIS administrative criteria for identifying diabetes cases to maximize specificity, and therefore were likely to select patients receiving more care for diabetes (see Table 1).(51) Such patients would be expected to be also treated for other conditions, including hyperlipidemia.”
MethodHunt, D., Young, P., Simes, J., Hague, W., Mann, S., Owensby, D., Lane, G., Tonkin, A., & for the LIPID Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00007 · Cited by 226 · cited 13×
“Of the 31350 patients in FY98 and 54855 patients in FY99 whose LDL-C values were greater than 130 mg/dL, 53.0% and 50%, respectively, were not receiving LLMs.”
BackgroundInfluentialVaccaro, O. (1998) · International Journal of Epidemiology · doi:10.1093/ije/27.4.636 · Cited by 69
Cited by
Racial Differences in the Prevalence of Severe Aortic Stenosis
Patel, D. K., Green, K. D., Fudim, M., Harrell, F. E., Wang, T. J., & Robbins, M. A. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000879 · Cited by 127
Strawbridge, L. M., Lloyd, J. T., Meadow, A., Riley, G. F., & Howell, B. L. (2017) · Medical Care · doi:10.1097/mlr.0000000000000653 · Cited by 96
Selby, J. V., Swain, B. E., Gerzoff, R. B., Karter, A. J., Waitzfelder, B. E., Brown, A. F., Ackermann, R. T., Duru, O. K., Ferrara, A., Herman, W., et al. (2007) · Medical Care · doi:10.1097/mlr.0b013e3181468e79 · Cited by 73
Pambianco, G., Lombardero, M., Bittner, V., Forker, A., Kennedy, F., Krishnaswami, A., Mooradian, A. D., Pop‐Busui, R., Rana, J. S., Rodriguez, A., et al. (2009) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.00014.x · Cited by 8
Metadata
- Authors
- Safford, M., Eaton, L., Hawley, G., Brimacombe, M., Rajan, M., Li, H., & Pogach, L.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2003-04-28
- Volume
- 163
- Issue
- 8
- Pages
- 922
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2082210701
- Cited by
- 54
- References
- 9
- FWCI
- 5.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus. https://app.cochat.ai/papers/10.1001/archinte.163.8.922
- The paper
- Safford, M., Eaton, L., Hawley, G., Brimacombe, M., Rajan, M., Li, H., & Pogach, L. (2003). Disparities in Use of Lipid-Lowering Medications Among People With Type 2 Diabetes Mellitus. Archives of Internal Medicine. https://doi.org/10.1001/archinte.163.8.922
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.